There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of Candesartan cilexetil
CAS No.: 145040-37-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Candesartan Cilexetil is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.
Synonyms: TCV-116; Candesartan M1 Cilexetil
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 145040-37-5 |
Formula : | C33H34N6O6 |
M.W : | 610.66 |
SMILES Code : | O=C(C1=C2N(CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)C(OCC)=NC2=CC=C1)OC(OC(OC6CCCCC6)=O)C |
Synonyms : |
TCV-116; Candesartan M1 Cilexetil
|
MDL No. : | MFCD00871371 |
InChI Key : | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
Pubchem ID : | 2540 |
GHS Pictogram: |
![]() |
Signal Word: | Danger |
Hazard Statements: | H360-H362 |
Precautionary Statements: | P501-P263-P260-P270-P202-P201-P264-P280-P308+P313-P405 |
Class: | 6.1 |
UN#: | 2811 |
Packing Group: | Ⅲ |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
Triple-negative breast cancer cells (MDA-MB-231, BT20) | IC50 ~18-20μM | 4 days | Evaluate the effect of Candesartan cilexetil on the viability of triple-negative breast cancer cells, showing significant inhibition of cell proliferation. | PMC10066340 |
Colorectal cancer cells (HT29, HCT116, DLD1) | IC50 ~15-17μM | 4 days | Evaluate the effect of Candesartan cilexetil on the viability of colorectal cancer cells, showing significant inhibition of cell proliferation. | PMC10066340 |
Pancreatic cancer cells (PANC1, MiaPaCa2, AsPC1) | IC50 ~20μM | 4 days | Evaluate the effect of Candesartan cilexetil on the viability of pancreatic cancer cells, showing significant inhibition of cell proliferation. | PMC10066340 |
Caco-2 cells | 5, 10, 20, 40, 80 µg/mL | 24 hours | To evaluate the biocompatibility of candesartan cilexetil and its formulations with Caco-2 cells. Results showed that the IC50 of free CC was 8.5 µg/mL (24 hours), while the IC50 of F7 and C1 niosomes was 29.5 µg/mL, indicating that niosomes reduced the cytotoxicity of the drug. | PMC8378936 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Sprague-Dawley rats | Bleomycin-induced pulmonary fibrosis model | Oral | 10 mg/kg/day | Once daily for 21 days | Candesartan cilexetil significantly inhibited the increase in total protein and albumin, as well as the increase in total cells and neutrophils in BAL fluid. On day 21 candesartan cilexetil also ameliorated morphological changes and an increased amount of hydroxyproline in lung homogenates. In addition, BLM increased the expression of transforming growth factor (TGF)-β1 in BAL fluid on day 7; this increase was significantly reduced by candesartan cilexetil. | PMC1758867 |
New Zealand White rabbits | Atherosclerosis model | Oral gavage | 0.5 mg/kg/d | Once daily for 8 weeks | Candesartan attenuated the degree of atherosclerosis, reduced the frequency of plaque disruption and thrombosis, decreased macrophage accumulation within the plaque, and increased collagen deposition. | PMC2906248 |
NSG mice | Pancreatic cancer (PANC1) and colorectal cancer (HT29) xenograft models | Oral gavage | 100 mg/kg | Daily administration for the duration of the experiment | Evaluate the inhibitory effect of Candesartan cilexetil on tumor growth, showing significant reduction in tumor volume without affecting body weight. | PMC10066340 |
Male KKAy diabetic mice | Diabetic model | Mixed in diet | 0.005% | 3 weeks | Comparison of the effects of candesartan cilexetil and azilsartan on vascular function in diabetic mice. Candesartan cilexetil did not significantly improve acetylcholine-induced endothelium-dependent relaxation, whereas azilsartan did. | PMC3916073 |
Sprague Dawley rats | Hypertension model | Oral | 50 mg/kg | Single dose | To evaluate the oral absolute bioavailability of candesartan cilexetil niosomes. Results showed that the bioavailability of F7-SMCC and C1-SMCC was 36.4% and 37.46%, respectively, significantly higher than that of free candesartan cilexetil (6.23%). | PMC8378936 |
UM-HET3 male mice | Genetically heterogeneous mouse model | Oral | 30 ppm | Continuous administration starting at 8 months of age | Tested the effect of candesartan cilexetil on lifespan; results showed no significant effect on lifespan in either male or female mice | PMC8135004 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00319202 | Glucose Intolerance ... More >> Obesity Less << | Phase 4 | Terminated(Difficulties in com... More >>pleting the required sample size) Less << | - | Colombia ... More >> Fundación Cardiovascular de Colombia Floridablanca, Santander, Colombia, 10000 Less << |
NCT01062451 | Methamphetamine Dependence ... More >> Methamphetamine Abuse Substance Abuse Less << | Phase 1 | Active, not recruiting | December 2018 | United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less << |
NCT00526279 | - | Completed | - | Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less << | |
NCT00802542 | - | Completed | - | Latvia ... More >> Research site Daugavpils, Latvia Research site Jelgava, Latvia Research site Liepaja, Latvia Research Site Riga, Latvia Less << | |
NCT00564057 | HIV Infections ... More >> Hypertension Less << | Phase 4 | Unknown | September 2009 | Italy ... More >> University of Insubria, Department of Clinical Medicine Recruiting Varese, Italy, 21100 Less << |
NCT00644475 | Essential Hypertension | Phase 3 | Unknown | March 2009 | Italy ... More >> University of Pavia Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD +39 0382 502614 giuseppe.derosa@unipv.it Contact: Roberto Fogari, MD +39 0382 526217 r.fogari@unipv.it Principal Investigator: Giuseppe Derosa, MD Less << |
NCT00150631 | Hypertension | Phase 3 | Unknown | December 2014 | Denmark ... More >> Karin Skov Aarhus, Denmark, 8000 Less << |
NCT01766505 | Hypertension | Phase 4 | Terminated(lack of the subject... More >>s) Less << | - | Korea, Republic of ... More >> Chunbuk National University Hospital Chonju, Korea, Republic of, 561-712 Presbyterian Medical Center Chunju, Korea, Republic of, 560-750 Chungnam national university hospital Daejeon, Korea, Republic of, 301-721 The catholic university of Korea, Daejeon st. Mary's Hospital Daejeon, Korea, Republic of, 301-723 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Konyang university hospital Daejon, Korea, Republic of, 302-718 Chunnam National University Hospital Gwangju, Korea, Republic of, 501-757 Kwangju Christian Hospital Gwangju, Korea, Republic of, 503-715 ST.Carollo hospital Suncheon, Korea, Republic of, 540-719 Less << |
NCT01682564 | Hypertension ... More >>Congestive Heart Failure Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Inje university pusan hospital Busan, Busanjin-gu Gaegum-dong, Korea, Republic of, 614-735 Gyeongsang national university hospital Jinju, Chiram-dong, Korea, Republic of, 660-702 Daegu fatima hospital Daegu, Dong-gu Sinam-dong, Korea, Republic of, 701-724 Daedong hospital Busan, Dongnae-gu Myeongnyun-dong, Korea, Republic of, 607-711 Inje university haeundae paik hospital Busan, Haeundae-gu Heaundae-ro 875, Korea, Republic of, 612-030 Maryknoll medical center Busan, Jung-gu Daecheong-dong, Korea, Republic of, 600-730 Keimyung university dongsan medical center Daegu, Jung-gu Dongsan-dong, Korea, Republic of, 700-712 Kyungpook national university hospital Daegu, Jung-gu Samdeok-dong, Korea, Republic of, 700-721 Samsung changwon hospital Changwon, Masanhoiwon-gu Hapseong-dong 50, Korea, Republic of, 630-723 Yeungnam university medical center Daegu, Nam-gu Daemyeong-dong, Korea, Republic of, 705-717 Daegu catholic univ. medical center Daegu, Nam-gu Daemyung-dong, Korea, Republic of, 705-718 Kosin university gospel hospital Busan, Seo-gu Amnam-dong, Korea, Republic of, 602-702 Dong-A university medical center Busan, Seo-gu Dongdaesin-dong, Korea, Republic of, 602-715 Dongguk university gyeongju hospital Gyeongju, Seokjang-dong, Korea, Republic of, 780-350 Less << |
NCT01303783 | Hypertension, Essential | Phase 2 | Completed | - | - |
NCT00459771 | Breast Cancer | Phase 3 | Completed | - | Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands Flevoziekenhuis Almere, Netherlands The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Slotervaart Hospital Amsterdam, Netherlands Wilhelmina Ziekenhuis Assen, Netherlands Jeroen Bosch Hospital Den Bosch, Netherlands Deventer Ziekenhuis Deventer, Netherlands Medisch Spectrum Twente Enschede, Netherlands Martini Ziekenhuis Groningen, Netherlands University Medical Center Groningen Groningen, Netherlands Ziekenhuis de Tjongerschans Heerenveen, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands Antonius Ziekenhuis Nieuwegein, Netherlands Canisius-Wilhelmina Hospital Nijmegen, Netherlands UMC St. Radboud Nijmegen, Netherlands VieCuri Medisch Centrum voor Noord-Limburg Venlo, Netherlands Streekziekenhuis Koningin Beatrix Winterswijk, Netherlands Isala Klinieken Zwolle, Netherlands Less << |
NCT00232882 | Hypertension | Phase 4 | Completed | - | Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 Less << |
NCT00884663 | Migraine Without Aura ... More >> Migraine With Aura Chronic Migraine Less << | Phase 2 Phase 3 | Completed | - | Norway ... More >> Norwegian National Headache Centre, St. Olavs University Hospital Trondheim, Norway, 7489 Less << |
NCT02064556 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less << |
NCT00244634 | Pediatric Hypertension | Phase 3 | Completed | - | - |
NCT02521246 | Essential Arterial Hypertensio... More >>n Less << | Phase 3 | Withdrawn(Sponsor decision) | August 2017 | - |
NCT02707224 | Healthy | Phase 1 | Completed | - | - |
NCT02609711 | Healthy Male Subjects | PHASE1 | UNKNOWN | - | Inha Univ. Hospital, Incheon, ... More >>Korea, Republic of Less << |
NCT02079506 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Chungnam National University Hospital Jung-gu, Daejeon, Korea, Republic of, 301-721 Less << |
NCT02651870 | Hypertension | Phase 3 | Unknown | February 2016 | Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Hoon Choi, M.D., Ph.D Principal Investigator: Dong-Hoon Choi, M.D, Ph.D Less << |
NCT00282178 | Hypertension ... More >>Obesity Less << | Phase 2 | Completed | - | Sweden ... More >> Umeå University Hospital Umeå, Sweden, SE-90185 Less << |
NCT02521233 | Essential Arterial Hypertensio... More >>n Less << | Phase 3 | Withdrawn(Sponsor decision) | August 2017 | - |
NCT00608153 | - | Completed | - | - | |
NCT01135212 | Hypertension | Phase 3 | Completed | - | Korea, Republic of ... More >> KyungPook National University Hospital Daegu, Korea, Republic of, 110-750 Less << |
NCT00244595 | Hypertension | Phase 3 | Completed | - | - |
NCT00607633 | - | Completed | - | - | |
NCT01152567 | - | Completed | - | - | |
NCT00125463 | Hypertension|Cardiovascular Di... More >>seases Less << | PHASE3 | UNKNOWN | 2025-12-05 | Kyoto University, Kyoto, Yoshi... More >>dakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan Less << |
NCT03688633 | Peripheral Neuropathy | Phase 2 | Not yet recruiting | June 1, 2021 | France ... More >> CHU Limoges Not yet recruiting Limoges, France, 87042 Contact: Laurent Magy, MD 05 55 05 65 68 laurent.magy@unilim.fr Less << |
NCT00573742 | - | Completed | - | Romania ... More >> Research Site Bacau, Romania Research Site Braila, Romania Research Site Brasov, Romania Research Site Bucuresti, Romania Research Site Cluj, Romania Research Site Constanta, Romania Research Site Craiova, Romania Research Site Galati, Romania Research Site Ghiroda, Romania Research Site Iasi, Romania Research Site Lugoj, Romania Research Site Oradea, Romania Research Site Pitesti, Romania Research Site Ploiesti, Romania Research Site Sibiu, Romania Research Site Timisoara, Romania Less << | |
NCT02261116 | Healthy | Phase 4 | Completed | - | - |
NCT00184587 | Cluster Headache | Phase 2 | Completed | - | Norway ... More >> Norwegian National Headache Centre St.Olavs Hospital Trondheim, Norway, 7006 Less << |
NCT00905333 | Healthy | Phase 1 | Completed | - | Brazil ... More >> Research Site Itatiba, SP, Brazil Research Site Americana, Brazil Less << |
NCT00679484 | Chronic Heart Failure ... More >> High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level Less << | Phase 3 | Terminated(Lack of subject rec... More >>ruitment) Less << | - | France ... More >> Bron, France Cedex, France Cholet, France Langres, France Mannheim, France Pontoise, France Roubaix, France Germany Bad Nauheim, Germany Berlin, Germany Lambrecht, Germany Netherlands Ad Delft, Netherlands Less << |
NCT02548286 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Jung-gu, Korea, Republic of Less << |
NCT00108706 | Cerebrovascular Accident ... More >> Acute Stroke Less << | Phase 4 | Unknown | - | United Kingdom ... More >> Sunderland Royal Hospital Sunderland, Tyne and Wear, United Kingdom, SR4 7TP Less << |
NCT02186496 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Chungcheongbuk-do, Korea, Republic of, 301-721 Less << |
NCT03231982 | Hypertension | Phase 4 | Recruiting | May 31, 2019 | Korea, Republic of ... More >> Yonsei University Severance Cardiovascular Hospital Recruiting Seoul, Korea, Republic of Contact: Donghoon Choi, M.D., Ph.D. 82-2-2228-8200 cdhlyj@yuhs.ac Less << |
NCT00775814 | Obesity Hyper... More >>tension Less << | Phase 4 | Completed | - | Germany ... More >> Bad Dürrheim, Baden-Württemberg, Germany Balingen, Baden-Württemberg, Germany Deggingen, Baden-Württemberg, Germany Rottweil, Baden-Württemberg, Germany Spaichingen, Baden-Württemberg, Germany Ingolstadt, Bayern, Germany München, Bayern, Germany Passau, Bayern, Germany Schauenburg, Hessen, Germany Bocholt, Nordrhein-Westfalen, Germany Essen, Nordrhein-Westfalen, Germany Isselburg, Nordrhein-Westfalen, Germany Köln, Nordrhein-Westfalen, Germany Roetgen, Nordrhein-Westfalen, Germany Troisdorf, Nordrhein-Westfalen, Germany Wesseling, Nordrhein-Westfalen, Germany Roedersheim-Gronau, Rheinland-Pfalz, Germany Dresden, Sachsen, Germany Freital, Sachsen, Germany Machem, Sachsen, Germany Markkleeberg, Sachsen, Germany Wermsdorf, Sachsen, Germany Bad Segeberg, Schleswig-Holstein, Germany Berlin, Germany Less << |
NCT01227603 | Hypertension, Essential | Phase 1 | Completed | - | Germany ... More >> Köln, Nordrhein-Westfalen, Germany, 51063 Less << |
NCT00400582 | Heart Failure | Phase 4 | Completed | - | Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less << |
NCT02811731 | Hypertension | Phase 1 | Completed | - | - |
NCT02988362 | Hypertension | Phase 1 | Unknown | March 2017 | - |
NCT01629225 | Essential Hypertension | Phase 4 | Unknown | July 2015 | China ... More >> Department of Cardiology, Daping Hospital, The Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Yu Changqing, MD changqingyu-2@163.com Less << |
NCT02801526 | Hypertension | Phase 1 | Completed | - | - |
NCT00843154 | Heart Failure | Phase 3 | Terminated(Insufficient enroll... More >>ment) Less << | - | - |
NCT02944734 | Essential Hypertension | Phase 2 | Completed | - | Korea, Republic of ... More >> Catholic University of Korea Bucheon St. Mary's Hospital Wonmi-gu, Bucheon, Korea, Republic of Inje University Busan Paik Hospital Busanjin-gu, Busan, Korea, Republic of Pusan National University Hospital Seo-gu, Busan, Korea, Republic of Keimyung University Dongsan Medical Center Joong-gu, Daegu, Korea, Republic of Kyungpook National University Hospital Joong-gu, Daegu, Korea, Republic of Daegu Catholic University Medical Center Nam- gu, Daegu, Korea, Republic of Dongguk University Ilsan Hospital Ilsandong-gu, Goyang-si, Gyeoggi-do, Korea, Republic of Chonnam National University Hospital Dong-Gu, Gwangju, Korea, Republic of Catholic University of Korea Uijeongbu St. Mary's hospital Uijeongbu-si, Gyeoggi-do, Korea, Republic of Gachon University Gil Hospital Namdong-gu, Incheon, Korea, Republic of St. Carollo General Hospital Suncheon-si, Jeollanam-do, Korea, Republic of Wonju Severance Christian Hospital Wonju, Kangwon-Do, Korea, Republic of Catholic University of Korea St. Paul's Hospital Dongdaemun-gu, Seoul, Korea, Republic of KyungHee University Medical Center Dongdaemun-gu, Seoul, Korea, Republic of Hallym University Kangdong Sacred Heart Hospital Gangdong-gu, Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Gangdong-Gu, Seoul, Korea, Republic of VHS( Veterans Medical Service) Medical Center Gangdong-gu, Seoul, Korea, Republic of Konkuk University Medical Center Gwangjin-gu, Seoul, Korea, Republic of Seoul National University Hospital Jongro-gu, Seoul, Korea, Republic of Catholic University of Korea Seoul St. Mary's Hospital Seocho-Gu, Seoul, Korea, Republic of Korea University Anam Hospital Seongbuk-Gu, Seoul, Korea, Republic of Catholic University of Korea Yeouido St. Mary's Hospital Yeongdeungpo-gu, Seoul, Korea, Republic of Ulsan University Hospital Dong-gu, Ulsan, Korea, Republic of Less << |
NCT00775840 | Heart Failure | Phase 3 | Completed | - | Germany ... More >> Bad Friedrichshall, Baden-Württemberg, Germany Heidelberg, Baden-Württemberg, Germany Ludwigsburg, Baden-Württemberg, Germany Bad Homburg, Hessen, Germany Bad Nauheim, Hessen, Germany Darmstadt, Hessen, Germany Frankfurt, Hessen, Germany Giessen, Hessen, Germany Kassel, Hessen, Germany Limburg, Hessen, Germany Melsungen, Hessen, Germany Mühlheim, Hessen, Germany Wiesbaden, Hessen, Germany Nienburg, Niedersachsen, Germany Northeim, Niedersachsen, Germany Weyhe, Niedersachsen, Germany Essen, Nordrhein-Westfalen, Germany Gelsenkirchen, Nordrhein-Westfalen, Germany Gladbeck, Nordrhein-Westfalen, Germany Langenfeld, Nordrhein-Westfalen, Germany Paderborn, Nordrhein-Westfalen, Germany Siegen, Nordrhein-Westfalen, Germany Bad Kreuznach, Rheinland-Pfalz, Germany Neukirchen, Saarland, Germany Coswig, Sachsen-Anhalt, Germany Dresden, Sachsen, Germany Hartmannsdorf, Sachsen, Germany Leipzig, Sachsen, Germany Leisnig, Sachsen, Germany Machem, Sachsen, Germany Markkleeberg, Sachsen, Germany Riesa, Sachsen, Germany Wermsdorf, Sachsen, Germany Erfurt, Thüringen, Germany Jena, Thüringen, Germany Nordhausen, Thüringen, Germany Berlin, Germany Less << |
NCT00620178 | - | Completed | - | Sweden ... More >> Research Site Uppsala, Sweden Less << | |
NCT00634400 | Congestive Heart Failure | Phase 3 | Completed | - | - |
NCT00120003 | Stroke | Phase 3 | Completed | - | Norway ... More >> Ullevaal University Hospital Oslo, Norway, NO-0407 Less << |
NCT01611077 | Hypertension | Phase 4 | Completed | - | Germany ... More >> Praxis Dr. Reimer Anderbeck, Germany, 38836 Praxis Dr. Heinz Bergisch-Gladbach, Germany, 51429 Praxis Dr. Zemmrich Berlin, Germany, 12043 St.-Josefs-Hospital Cloppenburg, Germany, 49661 Praxis Dr. Pohl Dresden, Germany, 01129 Praxis Dr. Koßler-Wiesweg Essen, Germany, 45138 Praxis Dr. Rövenich Frankfurt, Germany, 65929 Praxis Dr. Strzata Kapellendorf, Germany, 99510 Praxis Dr. Paschmionka Leipzig, Germany, 04316 Praxis Dr. Pitule Ludwigshafen, Germany, 67061 Praxis Dr. Loddo Rastede, Germany, 26180 Less << |
NCT00383929 | Hypertension | Phase 3 | Completed | - | - |
NCT01827202 | Hypertension ... More >>Chronic Kidney Disease Proteinuria Less << | Phase 4 | Completed | - | Austria ... More >> Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis Vienna, Austria, 1090 Less << |
NCT00348686 | - | Completed | - | - | |
NCT00348686 | Hypertension ... More >>Left Ventricular Hypertrophy Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Research Site BuSan, Korea, Republic of Research Site CheonAn, Korea, Republic of Research Site CheongJu, Korea, Republic of Research Site Chunbuk, Korea, Republic of Research Site DaeGu, Korea, Republic of Research Site DaeJeon, Korea, Republic of Research Site Gyungsangnamdo, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of Less << |
NCT02059616 | Essential Hypertension | Phase 2 | Unknown | December 2015 | Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Bundang, Korea, Republic of Dong-A University Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Konyang University Hospital Recruiting Daejeon, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Paik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Hallym University Sacred Heart hospital Recruiting Kyungki-do, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Pusan, Korea, Republic of Pusan National University Hospital Recruiting Pusan, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's hospital Recruiting Seoul, Korea, Republic of Severance Hospital Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seung-Jea Tahk Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less << |
NCT01806311 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... More >> Chungnam national university hospital,clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less << |
NCT02173912 | Healthy Volunteers | Phase 1 | Unknown | August 2014 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Chaeyeong Lee Principal Investigator: Jae-Wook Ko, MD Less << |
NCT02969265 | Hypertension | Phase 3 | Withdrawn(Business reasons unr... More >>elated to product safety) Less << | July 26, 2018 | - |
NCT01984164 | Hypertension ... More >>Mild Cognitive Impairment Less << | Phase 3 | Active, not recruiting | December 15, 2018 | United States, Georgia ... More >> Emory Univeristy Atlanta, Georgia, United States, 30329 Less << |
NCT02047019 | Hypertension | Phase 3 | Withdrawn(GPDC decided to term... More >>inate the study) Less << | December 8, 2019 | Italy ... More >> Fondazione Università G.D'Annunzio Chieti, Abruzzo, Italy, 66100 A.O.U. di Bologna Policlinico S.Orsola Malpighi Bologna, Emilia-Romagna, Italy, 40138 AAS 3 Friuli Alto Medio Collin Udine, Friuli-Venezia Giulia, Italy, 33038 Fondazione Salvatore Maugeri Pavia, Lombardia, Italy, 27100 IRCCS Ist Neurologico Mediterraneo Isernia, Molise, Italy, 86077 A.O.U. di Sassari Sassari, Sardegna, Italy, 07100 A.O.U. Pisana Pisa, Toscana, Italy, 56126 AULSS 07 Pieve Soligo Treviso, Veneto, Italy, 31029 Less << |
NCT03460327 | - | Recruiting | October 2026 | Norway ... More >> St. Olavs University Hospital Recruiting Trondheim, Norway Contact: Magnus Strømmen, MSc Less << | |
NCT00984529 | - | Completed | - | Croatia ... More >> Research Site Biograd, Croatia Research Site Bjelovar, Croatia Reserach Site Cakovec, Croatia Research Site Karlovac, Croatia Reserach Site Krapinske Toplice, Croatia Research Site Novi Marof, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Reserach Site Sl. Brod, Croatia Research Site Split, Croatia Research Site Stubicke Toplice, Croatia Reserach Site Zabok, Croatia Research Site Zagreb, Croatia Less << | |
NCT00244621 | - | Completed | - | - | |
NCT00699452 | Aortic Valve Stenosis | Phase 3 | Unknown | December 2014 | Finland ... More >> Division of Cardiology, Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Markku Kupari, MD, PhD 358-9-4717-2441 markku.kupari@hus.fi Contact: Satu Helske, MD, PhD 358-9-681-411 satu.helske@wri.fi Principal Investigator: Markku Kupari, MD, PhD Less << |
NCT00434967 | Hypertension | Phase 3 | Completed | - | Belgium ... More >> Research Site Dour, Belgium Research Site Gozée, Belgium Research Site Hasselt, Belgium Research Site Linkebeek, Belgium Research Site Marchovelette, Belgium Research Site Ronquières, Belgium Research Site Saint-Médard, Belgium Research Site Steenokkerzel, Belgium Latvia Research Site Daugavpils, Latvia Research Site Ogre, Latvia Research Site Riga, Latvia Malta Research Site Gozo, Malta Research Site Gwardiamangia, Malta Romania Research Site Arad, Romania Research Site Bucuresti, Romania Research Site Iasi, Romania Research Site Pitesti, Romania Research Site Ploiesti, Romania Research Site Targoviste, Romania Research Site Timisoara, Romania Russian Federation Research Site Moscow, Russian Federation Research Site St. Petersburg, Russian Federation Slovakia Research Site Bratislava, Slovakia Research Site Levice, Slovakia Research Site Lucenec, Slovakia Research Site Presov, Slovakia Research Site Sahy, Slovakia Less << |
NCT00434967 | - | Completed | - | - | |
NCT00244621 | Hypertension | Phase 3 | Completed | - | - |
NCT01938664 | Cocaine Dependence | Phase 2 | Completed | - | United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less << |
NCT02068495 | - | Completed | - | - | |
NCT00690612 | Hypertension | Phase 3 | Completed | - | Belgium ... More >> Research Site Edegem, Belgium Research Site Gent, Belgium France Research Site Strasbourg Cedex, France Germany Research Site Erlangen, Germany Research Site Heidelberg, Germany Research Site Marburg, Germany Research Site Rostock, Germany Italy Research Site Genova, GE, Italy Research Site Padova, PD, Italy Poland Research Site Gda�sk, Poland Research Site Krakow, Poland Ukraine Research Site Crimea, Ukraine Research Site Kyiv, Ukraine Less << |
NCT01350609 | Hypertension, Essential | Phase 1 | Completed | - | Germany ... More >> Berlin, Germany, 13353 Less << |
NCT02068495 | - | Completed | - | - | |
NCT00679640 | - | Completed | - | - | |
NCT00139386 | Hypertension ... More >>Coronary Artery Disease Less << | Phase 4 | Completed | - | Japan ... More >> Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan, 860-8556 Less << |
NCT02094924 | Hypertension | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less << |
NCT00634309 | Congestive Heart Failure | Phase 3 | Completed | - | - |
NCT00690612 | - | Completed | - | - | |
NCT03136666 | Clinical Pharmacology | Phase 1 | Completed | - | Germany ... More >> Wuppertal, Nordrhein-Westfalen, Germany, 42096 Less << |
NCT00573430 | Non-diabetic Nephropathy With ... More >>Hypertension Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less << |
NCT00634712 | Congestive Heart Failure | Phase 3 | Completed | - | - |
NCT00844324 | Hypertension | Phase 1 | Completed | - | United Kingdom ... More >> Research Site Harrow, United Kingdom Less << |
NCT01976572 | Hyperphosphatemia ... More >> Chronic Kidney Disease Less << | Phase 1 | Completed | - | United Kingdom ... More >> Covance Clinical Research Unit Ltd. Leeds, Springfield House Hyde Street, United Kingdom Less << |
NCT00573430 | - | Completed | - | - | |
NCT00990639 | Alcoholic Liver Disease | Phase 1 Phase 2 | Completed | - | Korea, Republic of ... More >> Yonsei University Wonju College of Medicine Wonju Christian Hospital Wonju, Kangwon-do, Korea, Republic of, 220-701 Less << |
NCT01976572 | - | Completed | - | - | |
NCT00252720 | Type 1 Diabetes | Phase 3 | Completed | - | - |
NCT00252720 | - | Completed | - | - | |
NCT00227318 | Hypertension | Phase 3 | Completed | - | - |
NCT01788358 | Hypertension | Phase 3 | Completed | - | - |
NCT00252694 | - | Completed | - | - | |
NCT00252733 | Type 1 Diabetes | Phase 3 | Completed | - | Australia ... More >> Research Site Herston, Australia Research Site Perth, Australia Denmark Research Site Odense, Denmark Less << |
NCT02016183 | - | Completed | - | Japan ... More >> Tokyo, Japan Less << | |
NCT00252694 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT01788358 | - | Completed | - | - | |
NCT01012479 | Hypertension | Phase 4 | Completed | - | Germany ... More >> Berlin, Germany Blankenhain, Germany Dortmund, Germany Hamburg, Germany Köthen, Germany Löhne, Germany Nürnberg, Germany Remscheid, Germany Rodgau, Germany Stockach, Germany Wardenburg, Germany Weinheim, Germany Ukraine Ivano-Frankivsk, Ukraine Kharkiv, Ukraine Kiev, Ukraine Lviv, Ukraine Less << |
NCT02016183 | - | Completed | - | - | |
NCT00252733 | - | Completed | - | - | |
NCT00621153 | - | Completed | - | - | |
NCT00621153 | Stage II Hypertension | Phase 4 | Completed | - | Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less << |
NCT00242346 | Proteinuria | Phase 3 | Completed | - | Canada, Alberta ... More >> Research Site Calgary, Alberta, Canada Research Site Edmonton, Alberta, Canada Canada, British Columbia Research Site Kelowna, British Columbia, Canada Research Site Vancouver, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, Newfoundland and Labrador Research Site St. John, Newfoundland and Labrador, Canada Canada, Nova Scotia Research Site Halifax, Nova Scotia, Canada Canada, Ontario Research Site Courtice, Ontario, Canada Research Site Kitchener, Ontario, Canada Research Site London, Ontario, Canada Research Site Mississauga, Ontario, Canada Research Site Oakville, Ontario, Canada Research Site Oshawa, Ontario, Canada Research Site Richmond Hill, Ontario, Canada Research Site Scarborough, Ontario, Canada Research Site Sudbury, Ontario, Canada Research Site Thunder Bay, Ontario, Canada Research Site Timmins, Ontario, Canada Research Site Toronto, Ontario, Canada Research Site Weston, Ontario, Canada Canada, Quebec Research Site Greenfield Park, Quebec, Canada Research Site Laval, Quebec, Canada Research Site Montreal, Quebec, Canada Research Site Quebec City, Quebec, Canada Research Site Ste-Foy, Quebec, Canada Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada Less << |
NCT02368665 | Essential Hypertension | Phase 3 | Unknown | June 2016 | Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less << |
NCT02646982 | Mild Cognitive Impairment | Phase 2 | Recruiting | September 2021 | United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Ihab Hajjar, MD 404-712-7250 ihajjar@emory.edu Principal Investigator: Ihab Hajjar, MD Wesley Woods Center Recruiting Atlanta, Georgia, United States, 30329 Contact: Ihab Hajjar, MD 404-712-7250 ihajjar@emory.edu Less << |
NCT01926652 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Chungnam national university hospital, clinical trial center Daejeon, Chungcheongbul-do, Korea, Republic of, 301-721 Less << |
NCT02254447 | Cardiovascular Disease | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less << |
NCT02368652 | Essential Hypertension | Phase 3 | Unknown | June 2016 | Korea, Republic of ... More >> Hallym University Sungsim Hospital Recruiting Anyang-si, Korea, Republic of Inje University Busan Baik Hospital Recruiting Busan, Korea, Republic of Inje University Haeundae Baik Hospital Recruiting Busan, Korea, Republic of Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of Chonnam National University Hospital Recruiting Gwangju, Korea, Republic of Inje University Ilsan Baik Hospital Recruiting Ilsan, Korea, Republic of Inha University Hospital Recruiting Incheon, Korea, Republic of Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Gangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Seoul Medical Center Recruiting Seoul, Korea, Republic of Seoul St. Mary's Hospital Catholic University Recruiting Seoul, Korea, Republic of Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of Ajou University Hospital Recruiting Suwon, Korea, Republic of Principal Investigator: Seungjae Tahk Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Less << |
NCT02064621 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of Less << |
NCT02006602 | Hypertension | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less << |
NCT01845272 | Healthy | Phase 1 | Unknown | August 2013 | - |
NCT02166697 | - | Completed | - | - | |
NCT02166697 | - | Completed | - | - | |
NCT02211638 | - | Completed | - | - | |
NCT02211638 | - | Completed | - | Japan ... More >> Osaka, Japan Less << | |
NCT02006589 | Hypertension | Phase 1 | Completed | - | India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.64mL 0.33mL 0.16mL |
8.19mL 1.64mL 0.82mL |
16.38mL 3.28mL 1.64mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|